← Open Payments lookup

JUDY CLARK: Open Payments

NPI 1770119257 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,760 in 81 payments from 11 companies in 2025. Trend: 2023 $2,264 · 2024 $1,995 · 2025 $2,760

Food & beverage: $2,760
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.13$535
ABBVIE INC.19$402
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$320
Otsuka America Pharmaceutical, Inc.14$316
Axsome Therapeutics, Inc.9$298
Alkermes, Inc.2$233
Neurocrine BioSciences, Inc.2$223
Takeda Pharmaceuticals U.S.A., Inc.7$118
Tris Pharma Inc1$110
Janssen Pharmaceuticals, Inc5$105

Products named: FANAPT, VRAYLAR, CAPLYTA, Auvelity, REXULTI, LYBALVI, INGREZZA, TRINTELLIX.

Industry payments across AL — which companies pay providers there.